Grifols In Talks to Refinance Debt, Credit Line, CEO Says
This article is for subscribers only.
The embattled Spanish drugmaker Grifols SA is in talks with banks to refinance bonds due next year and extend a revolving credit line — together about €1.4 billion ($1.48 billion) — as it seeks to quell investor concerns about its ability to meet obligations.
“Plan A is to refinance” the €370 million in bonds due in 2025, Chief Executive Officer Nacho Abia told Bloomberg in a phone interview Thursday. “We could look at repaying it with our cash flow, but we don’t want to be too tight.” The drugmaker is also in talks about extending a $1 billion revolving credit facility due in November 2025, he said.